To assess the association of SOX2 signature with clinically recognised subtypes of HNSCC, we performed subset analyses using the expression data of the TCGA and Leipzig cohorts (Supplementary Fig. 2). This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.